Literature DB >> 19796527

Quality of life and its relation with disease severity in Behçet's disease.

I Ertam1, G Kitapcioglu, K Aksu, G Keser, A Ozaksar, H Elbi, I Unal, S Alper.   

Abstract

OBJECTIVE: Since Behçet's disease (BD) is a systemic vasculitis, it may deteriorate the quality of life of the patients. We aimed to investigate the relationship between the disease severity and the quality of life in patients with BD.
METHODS: We studied 195 BD patients and 195 healthy controls who were matched with regard to age, gender and socio-economic status. Krause score was calculated to assess disease severity, while Short-form-36 (SF-36) and The World Health Organization Quality of Life (WHOQOL-100) were used to evaluate the quality of life in BD.
RESULTS: The overall SF-36 and WHOQOL-100 scale scores, as well as their domains were significantly lower in BD patients. In BD patients, "general health", "role-physical", domains of SF-36, and "psychological", "level of independence", "environment", "environmental-public" domains of WHOQOL-100 showed significantly negative linear correlations with Krause scores. In BD patients with arthritis, the scores of "general health", "physical functioning", "role emotional" domains of SF-36, and the scores of "psychological", "level of independence" and "social relations" domains of WHOQOL-100 were significantly worse than without arthritis. The scores of "pain" domain of SF-36 and "level of independence" domain of WHOQOL-100 were significantly worse in BD patients with vascular involvement, while the scores of "mental health" domain of SF-36 and "psychological" domain of WHOQOL-100 were significantly worse in BD patients with eye involvement.
CONCLUSION: Based on the evaluation of SF-36 and WHOQOL-100 scores, quality of life is impaired and related with disease severity in BD. Arthritis, eye involvement and vascular involvement seem to contribute to this impairment.

Entities:  

Mesh:

Year:  2009        PMID: 19796527

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  18 in total

1.  Fibromyalgia in Behçet's disease: a narrative review.

Authors:  Claire Jobanputra; Roberta H Richey; Jagdish Nair; Robert J Moots; Andreas Goebel
Journal:  Br J Pain       Date:  2017-03-22

2.  Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Authors:  Claudia Fabiani; Antonio Vitale; Ida Orlando; Jurgen Sota; Marco Capozzoli; Rossella Franceschini; Mauro Galeazzi; Gian Marco Tosi; Bruno Frediani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2017-06-15       Impact factor: 3.397

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

4.  Identification of physical and psychosocial problems based on symptoms in patients with Behçet's disease.

Authors:  Hideyo Tsutsui; Hirotoshi Kikuchi; Hiroko Oguchi; Kyoko Nomura; Takayoshi Ohkubo
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

5.  Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity.

Authors:  Sevim Bavbek; Seçil Kepil Özdemir; Beyza Doğanay Erdoğan; Işıl Karaboğa; Suna Büyüköztürk; Aslı Gelincik; İnsu Yılmaz; Özlem Göksel; Adile Berna Dursun; Gül Karakaya; Ali Fuat Kalyoncu; Ferhan Özşeker; Gülden Paşaoğlu Karakış; Ferda Öner Erkekol; Gözde Köycü; Metin Keren; Ilaria Baiardini; Antonino Romano
Journal:  Qual Life Res       Date:  2015-06-20       Impact factor: 4.147

Review 6.  [The significance of health-related quality of life in systemic vasculitides].

Authors:  K Herlyn; F Moosig; W L Gross
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

7.  Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.

Authors:  Gülen Hatemi; Alfred Mahr; Mitsuhiro Takeno; Doyoung Kim; Melike Melikoğlu; Sue Cheng; Shannon McCue; Maria Paris; Mindy Chen; Yusuf Yazici
Journal:  RMD Open       Date:  2022-07

8.  Does Behcet's disease associate with neuropathic pain syndrome and impaired well-being?

Authors:  Deniz Evcik; Sebnem Koldas Dogan; Saime Ay; Nihan Cuzdan; Munevver Guven; Aysel Gurler; Ayse Boyvat
Journal:  Clin Rheumatol       Date:  2012-09-22       Impact factor: 2.980

9.  Validity and reliability of the Persian version of Behçet's disease quality-of-life (BD-QoL) questionnaire: a cross-cultural adaptation.

Authors:  Mahdi Vojdanian; Seyedeh Tahereh Faezi; Alan Tennant; Ann W Morgan; Pedram Paragomi; Mostafa Qorbani; Maryam Mattaji; Fereydoun Davatchi
Journal:  Rheumatol Int       Date:  2014-09-13       Impact factor: 2.631

10.  Cross-cultural adaptation and validation of Behçet's disease quality of life questionnaire.

Authors:  Zahi Touma; Lilian Ghandour; Abla Sibai; Houry Puzantian; Ayad Hamdan; Omar Hamdan; Jeanine Menassa; Imad Uthman; Thurayya Arayssi
Journal:  BMC Med Res Methodol       Date:  2011-04-20       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.